Dr. Juwe D. Kercula, PharmD, BPharm, BSc, FCT
Head, Clinical Trials & Pharmacovigilance Unit
Liberia Medicines & Health Products Regulatory Authority (LMHRA)
Dr. Juwe D. Kercula is a prominent figure in Liberia’s health sector, particularly in the field of Clinical Trials, Pharmacovigilance and regulatory practices. He serves as the head of the Clinical Trials Unit at the Liberia Medicines and Health Products Regulatory Authority (LMHRA). Dr. Kercula has played a crucial role in the development of Liberia’s first Clinical Trials and Pharmacovigilance guidelines and regulations which aim to enhance effective clinical trials oversight and monitoring of medicines safety in Liberia.
Since 2018, Dr. Kercula has been involved in capacity-building efforts through his collaboration with the VaccTrain project of the Paul Ehrlich Institute, working to develop key regulatory documents and improve oversight of clinical trials. Dr. Kercula have served as speaker at the Scientific Conference on Medical Products Regulations in Africa (SCoMRA IV, V & VI) where he shared LMHRA Clinical Trials Oversight experiences through the Ebola and COVID-19. He has also represented Liberia at several international forums and inspections, promoting good clinical practices and regulatory harmonization across Africa. Dr. Kercula serves as a member of the West Africa Health Organization (WAHO) Expert Working Committee on Clinical Trials.
His contributions have been instrumental in shaping Liberia’s response to health crises, ensuring transparency and efficiency in approving clinical trials for new treatments and vaccines and establishment of the LMHRA adverse drug reactions platform for the monitoring of the safety of medicines and health products including vaccines.
